Table 4.
Characteristic | No. | Log(SRFP4) | Spearman’s Rho | p-Value |
---|---|---|---|---|
Mean ± SEM | ||||
Previous myocardial infarction | 0.13 | 0.007 | ||
No | 282 | 1.04 ± 0.1 | ||
Yes | 222 | 1.08 ± 0.1 | ||
Previous PCI | 0.17 | 0.001 | ||
No | 167 | 1.03 ± 0.1 | ||
Yes | 337 | 1.07 ± 0.1 | ||
Previous cardiac bypass operation | 0.13 | 0.005 | ||
No | 441 | 1.05 ± 0.1 | ||
Yes | 63 | 1.10 ± 0.1 | ||
Previous stroke | 0.11 | 0.026 | ||
No | 451 | 1.05 ± 0.1 | ||
Yes | 53 | 1.10 ± 0.2 | ||
T2DM | 0.11 | 0.011 | ||
No | 266 | 1.04 ± 0.1 | ||
Yes | 238 | 1.07 ± 0.1 | ||
Insulin therapy | 0.17 | 0.001 | ||
No | 429 | 1.05 ± 0.1 | ||
Yes | 75 | 1.10 ± 0.2 | ||
Metabolic syndrome | 0.16 | <0.0001 | ||
No | 177 | 1.02 ± 0.1 | ||
Yes | 327 | 1.08 ± 0.1 |
Mean (log)SFRP4 concentrations were compared between strata of categorical variables by Spearman’s rank correlation test; no association between SFRP4 and parameters other than the listed.